DK0966683T3 - Assays, midler, terapi og diagnose vedrørende moduleirng af cellulær DNA-reparationsaktivitet - Google Patents

Assays, midler, terapi og diagnose vedrørende moduleirng af cellulær DNA-reparationsaktivitet

Info

Publication number
DK0966683T3
DK0966683T3 DK98900589T DK98900589T DK0966683T3 DK 0966683 T3 DK0966683 T3 DK 0966683T3 DK 98900589 T DK98900589 T DK 98900589T DK 98900589 T DK98900589 T DK 98900589T DK 0966683 T3 DK0966683 T3 DK 0966683T3
Authority
DK
Denmark
Prior art keywords
dna repair
agents
assays
dna
cellular dna
Prior art date
Application number
DK98900589T
Other languages
English (en)
Inventor
Stephen Philip Jackson
Susan Elizabeth Critchlow
Original Assignee
Kudos Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700574.8A external-priority patent/GB9700574D0/en
Priority claimed from GBGB9713131.2A external-priority patent/GB9713131D0/en
Application filed by Kudos Pharm Ltd filed Critical Kudos Pharm Ltd
Application granted granted Critical
Publication of DK0966683T3 publication Critical patent/DK0966683T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/9015Ligases (6)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98900589T 1997-01-13 1998-01-13 Assays, midler, terapi og diagnose vedrørende moduleirng af cellulær DNA-reparationsaktivitet DK0966683T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9700574.8A GB9700574D0 (en) 1997-01-13 1997-01-13 Methods and means relating to retrotransposon and retroviral integration
GBGB9713131.2A GB9713131D0 (en) 1997-06-20 1997-06-20 Assays,therapeutic and diagnostic methods and means
PCT/GB1998/000095 WO1998030902A1 (en) 1997-01-13 1998-01-13 Assays, agents, therapy and diagnosis relating to modulation of cellular dna repair activity

Publications (1)

Publication Number Publication Date
DK0966683T3 true DK0966683T3 (da) 2003-08-04

Family

ID=26310785

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98900589T DK0966683T3 (da) 1997-01-13 1998-01-13 Assays, midler, terapi og diagnose vedrørende moduleirng af cellulær DNA-reparationsaktivitet

Country Status (12)

Country Link
US (1) US6753158B1 (da)
EP (1) EP0966683B1 (da)
JP (1) JP2001508868A (da)
AT (1) ATE237136T1 (da)
AU (1) AU724108B2 (da)
CA (1) CA2277481A1 (da)
DE (1) DE69813194T2 (da)
DK (1) DK0966683T3 (da)
ES (1) ES2197453T3 (da)
GB (1) GB2322193B (da)
PT (1) PT966683E (da)
WO (1) WO1998030902A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569681B1 (en) 2000-03-14 2003-05-27 Transkaryotic Therapies, Inc. Methods of improving homologous recombination
DE10161829B4 (de) * 2001-12-15 2006-02-16 Peter Lahnert Neue Methode zur Bestimmung der Telomerlänge und ihre Verwendung zur Abschätzung des Lebensalters
PL2295056T3 (pl) * 2004-03-15 2016-07-29 Sunesis Pharmaceuticals Inc Zastosowanie SNS-595 do leczenia białaczki
US8580814B2 (en) 2006-04-03 2013-11-12 Sunesis Pharmaceuticals, Inc. Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
US8124773B2 (en) 2006-06-12 2012-02-28 Sunesis Pharmaceuticals, Inc. 1,8-naphthyridine compounds for the treatment of cancer
US20130273656A1 (en) * 2010-10-08 2013-10-17 Regents Of The University Of Minnesota Method to increase gene targeting frequency
EP2983665A1 (en) * 2013-03-15 2016-02-17 The Regents of The University of California Therapeutic agents and methods for the treatment of dna repair deficiency disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07505057A (ja) * 1993-01-21 1995-06-08 ザ サルク インスティテュート フォー バイオロジカル スタディーズ プロテインキナーゼ
WO1995010288A1 (en) * 1993-10-12 1995-04-20 Baylor College Of Medicine Hepatitis b virus interacts with cellular dna repair processes
AU2201695A (en) * 1995-03-31 1996-10-16 Human Genome Sciences, Inc. Human dna ligase iii

Also Published As

Publication number Publication date
ATE237136T1 (de) 2003-04-15
DE69813194T2 (de) 2004-02-05
ES2197453T3 (es) 2004-01-01
GB2322193B (en) 1999-09-29
WO1998030902A1 (en) 1998-07-16
GB2322193A (en) 1998-08-19
PT966683E (pt) 2003-08-29
EP0966683A1 (en) 1999-12-29
US6753158B1 (en) 2004-06-22
DE69813194D1 (de) 2003-05-15
AU724108B2 (en) 2000-09-14
EP0966683B1 (en) 2003-04-09
GB9800663D0 (en) 1998-03-11
CA2277481A1 (en) 1998-07-16
JP2001508868A (ja) 2001-07-03
AU5568198A (en) 1998-08-03

Similar Documents

Publication Publication Date Title
IL142636A0 (en) A system for cell-based screening
IL147793A0 (en) Optical system analysis of cells
DE69636216D1 (de) Zusammensetzungen und verfahren zur behandlung und diagnose von immunstörungen
IL144797A0 (en) A system for cell-based screening
ATE109685T1 (de) Selbstständige testanordnung.
ES2053532T3 (es) Metodos de inmunoensayo.
ATE335200T1 (de) Diagnose von zellenproliferation sowie screeningverfahren für deren modulatore
ES2080044T3 (es) Moleculas de adhesion intercelular y sus ligandos de fijacion.
BR9909418A (pt) Antagonistas para o tratamento de distúrbios mediados por receptor de aderência cd11/cd18 e método para tratar ou melhorar uma resposta ou distúrbio imunológico ou inflamatório em um mamìfero mediada através da famìlia cd11/cd18 em moléculas de aderência celular
BR0303011A (pt) Painel de diagnóstico de câncer
DK412589D0 (da) Alfa-underenheden af lfa-1-leukocytadhaesionsreceptoren
WO1999066324A3 (en) A bioluminescence resonance energy transfer (bret) system and its use
DE69838090D1 (de) Mehrgefässplatten mit kleiner störstrahlung für fluoreszenzmessungen von biologischen und biochemischen proben
DK0966683T3 (da) Assays, midler, terapi og diagnose vedrørende moduleirng af cellulær DNA-reparationsaktivitet
BR8606994A (pt) Linha de celula hibrida,anticorpo monoclonal especifico para um editopo de glicoforina a e processo de ensaio da populacao de leucocitos em uma a mostra de sague humano periferi co
DE69934418D1 (de) MUTIERTE MITGLIEDER DER TGF-BETA-SUPERFAMILIE, EINSCHLIEßLICH MORPHOGENETISCHER PROTEINE
ATE168781T1 (de) Neue antikoagulant-cofaktor aktivität
ATE540966T1 (de) Von phenoxazinon abgeleitete neue enzymsubstrate und deren verwendung als entwickler bei der detektion von mikroorganismen mit peptidaseaktivität
WO1997040379A3 (en) Assays and reagents for identifying modulators of cdc25-mediated mitotic activation
DE3585049D1 (de) Monoklonale antikoerper.
ES550768A0 (es) Procedimiento para la determinacion especifica de alfa-ami- lasa
Asner Predictors of mental health among Central American immigrants.(depression, ethnic identity, intimacy).
ATE430196T1 (de) Mekk1 serin threonin kinasen -fha forkhead verbundenes bereich -interagierendes protein 1 (mif1)
ATE386142T1 (de) Fluoreszenz-basierte assays von dns-primasen
DE69502099D1 (de) Paracetamolphosphat für immunoassays